Linked Data API

Show Search Form

Search Results

79736
registered interest false more like this
date remove filter
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Multiple Sclerosis more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government whether Cladribine is available for people with multiple<i></i>sclerosis through the National Health Service; and, if not, what steps they are taking to make it available. more like this
tabling member printed
Baroness Gardner of Parkes more like this
uin HL1628 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-08-18more like thismore than 2014-08-18
answer text <p>Cladribine is not licensed for the treatment of multiple sclerosis.</p><p><strong> </strong></p><p>Prescribers can prescribe a medicine “off label” for unlicensed indications if they consider it to be of benefit to the patient and on condition that they retain full clinical responsibility for that patient.</p><p> </p><p>The National Institute for Health Research Horizon Scanning Centre published a report on cladribine for multiple sclerosis in 2008 and this is available at:</p><p> </p><p>www.hsc.nihr.ac.uk/topics/cladribine-movectro-for-multiple-sclerosis-relapsi</p><p> </p><p>We have made no assessment of research undertaken in other countries.</p><p> </p> more like this
answering member printed Earl Howe more like this
grouped question UIN HL1629 more like this
question first answered
less than 2014-08-18T10:12:15.9629235Zmore like thismore than 2014-08-18T10:12:15.9629235Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
3596
label Biography information for Baroness Gardner of Parkes more like this